BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21391686)

  • 21. Inhibition of human topoisomerase I and II and anti-proliferative effects on MCF-7 cells by new titanocene complexes.
    Chimento A; Saturnino C; Iacopetta D; Mazzotta R; Caruso A; Plutino MR; Mariconda A; Ramunno A; Sinicropi MS; Pezzi V; Longo P
    Bioorg Med Chem; 2015 Nov; 23(22):7302-12. PubMed ID: 26526741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological evaluation of novel thiomaltol-based organometallic complexes as topoisomerase IIα inhibitors.
    Legina MS; Nogueira JJ; Kandioller W; Jakupec MA; González L; Keppler BK
    J Biol Inorg Chem; 2020 May; 25(3):451-465. PubMed ID: 32193613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
    Minniti E; Byl JAW; Riccardi L; Sissi C; Rosini M; De Vivo M; Minarini A; Osheroff N
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4687-4693. PubMed ID: 28919339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors.
    Park S; Hong E; Kwak SY; Jun KY; Lee ES; Kwon Y; Na Y
    Eur J Med Chem; 2016 Nov; 123():211-225. PubMed ID: 27484510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, biological evaluation and modeling studies of terphenyl topoisomerase IIα inhibitors as anticancer agents.
    Qiu J; Zhao B; Zhong W; Shen Y; Lin H
    Eur J Med Chem; 2015 Apr; 94():427-35. PubMed ID: 25800514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents.
    Alam R; Wahi D; Singh R; Sinha D; Tandon V; Grover A; Rahisuddin
    Bioorg Chem; 2016 Dec; 69():77-90. PubMed ID: 27744115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones.
    Da Silva JG; Recio Despaigne AA; Louro SR; Bandeira CC; Souza-Fagundes EM; Beraldo H
    Eur J Med Chem; 2013 Jul; 65():415-26. PubMed ID: 23747809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression.
    Daumar P; Zeglis BM; Ramos N; Divilov V; Sevak KK; Pillarsetty N; Lewis JS
    Eur J Med Chem; 2014 Oct; 86():769-81. PubMed ID: 25240701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-Flourophenyl-substituted 5H-indeno[1,2-b]pyridinols with enhanced topoisomerase IIα inhibitory activity: Synthesis, biological evaluation, and structure-activity relationships.
    Kunwar S; Hwang SY; Katila P; Seo M; Man Kadayat T; Kwon Y; Lee ES
    Bioorg Chem; 2021 Nov; 116():105349. PubMed ID: 34536927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human topoisomerase IB is a target of a thiosemicarbazone copper(II) complex.
    Vutey V; Castelli S; D'Annessa I; Sâmia LB; Souza-Fagundes EM; Beraldo H; Desideri A
    Arch Biochem Biophys; 2016 Sep; 606():34-40. PubMed ID: 27431056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
    Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y
    Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
    Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF
    Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer potency of copper(II) complexes of thiosemicarbazones.
    Singh NK; Kumbhar AA; Pokharel YR; Yadav PN
    J Inorg Biochem; 2020 Sep; 210():111134. PubMed ID: 32673842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of imidazopyridinyl-1,3,4-oxadiazole conjugates as apoptosis inducers and topoisomerase IIα inhibitors.
    Subba Rao AV; Vishnu Vardhan MV; Subba Reddy NV; Srinivasa Reddy T; Shaik SP; Bagul C; Kamal A
    Bioorg Chem; 2016 Dec; 69():7-19. PubMed ID: 27656775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of friedelan triterpenoid analogs with DNA topoisomerase IIα inhibitory activity and their molecular docking studies.
    Mandal A; Ghosh S; Bothra AK; Nanda AK; Ghosh P
    Eur J Med Chem; 2012 Aug; 54():137-43. PubMed ID: 22633831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyridoxal hydrochloride thiosemicarbazones with copper ions inhibit cell division via Topo-I and Topo-IIɑ.
    Qi J; Zheng Y; Li B; Ai Y; Chen M; Zheng X
    J Inorg Biochem; 2022 Jul; 232():111816. PubMed ID: 35405490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Nitro-Thiophene-Thiosemicarbazone Derivatives Present Antitumor Activity Mediated by Apoptosis and DNA Intercalation.
    Roque Marques KM; do Desterro MR; de Arruda SM; de Araújo Neto LN; do Carmo Alves de Lima M; de Almeida SMV; da Silva ECD; de Aquino TM; da Silva-Júnior EF; de Araújo-Júnior JX; de M Silva M; de A Dantas MD; Santos JCC; Figueiredo IM; Bazin MA; Marchand P; da Silva TG; Mendonça Junior FJB
    Curr Top Med Chem; 2019; 19(13):1075-1091. PubMed ID: 31223089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction study with DNA/HSA, anti-topoisomerase IIα, cytotoxicity and in vitro antiproliferative evaluations and molecular docking of indole-thiosemicarbazone compounds.
    Jacob IT; da Cruz Filho IJ; Alves JEF; de Melo Souza F; de Azevedo RDS; Marques DSC; de Lima Souza TRC; Dos Santos KL; da Rocha Pitta MG; de Melo Rêgo MJB; Oliveira JF; Almeida SMV; do Carmo Alves de Lima M
    Int J Biol Macromol; 2023 Apr; 234():123606. PubMed ID: 36773880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.
    Kou JF; Qian C; Wang JQ; Chen X; Wang LL; Chao H; Ji LN
    J Biol Inorg Chem; 2012 Jan; 17(1):81-96. PubMed ID: 21858685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors.
    Tabrizi MA; Baraldi PG; Baraldi S; Prencipe F; Preti D; Saponaro G; Romagnoli R; Gessi S; Merighi S; Stefanelli A; Fazzi D; Borea PA; Maia RC; Romeiro NC; Fraga CA; Barreiro EJ
    Med Chem; 2015; 11(4):342-53. PubMed ID: 25494808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.